Review



line immunoassay  (Fujirebio Inc)


Bioz Verified Symbol Fujirebio Inc is a verified supplier
Bioz Manufacturer Symbol Fujirebio Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Fujirebio Inc line immunoassay
    Line Immunoassay, supplied by Fujirebio Inc, used in various techniques. Bioz Stars score: 95/100, based on 200 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/line immunoassay/product/Fujirebio Inc
    Average 95 stars, based on 200 article reviews
    line immunoassay - by Bioz Stars, 2026-02
    95/100 stars

    Images



    Similar Products

    line immunoassay  (Fujirebio Inc)
    95
    Fujirebio Inc line immunoassay
    Line Immunoassay, supplied by Fujirebio Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/line immunoassay/product/Fujirebio Inc
    Average 95 stars, based on 1 article reviews
    line immunoassay - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    line-immunoassay recomline sars-cov-2 igg  (Mikrogen Diagnostik)
    90
    Mikrogen Diagnostik line-immunoassay recomline sars-cov-2 igg
    Line Immunoassay Recomline Sars Cov 2 Igg, supplied by Mikrogen Diagnostik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/line-immunoassay recomline sars-cov-2 igg/product/Mikrogen Diagnostik
    Average 90 stars, based on 1 article reviews
    line-immunoassay recomline sars-cov-2 igg - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    myositis line immunoassay a1  (EUROIMMUN)
    90
    EUROIMMUN myositis line immunoassay a1
    Myositis Line Immunoassay A1, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/myositis line immunoassay a1/product/EUROIMMUN
    Average 90 stars, based on 1 article reviews
    myositis line immunoassay a1 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    euroline line dot immunoassay  (EUROIMMUN)
    90
    EUROIMMUN euroline line dot immunoassay
    Euroline Line Dot Immunoassay, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/euroline line dot immunoassay/product/EUROIMMUN
    Average 90 stars, based on 1 article reviews
    euroline line dot immunoassay - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    line immunoassays euroimmun antibody  (EUROIMMUN)
    90
    EUROIMMUN line immunoassays euroimmun antibody
    Line Immunoassays Euroimmun Antibody, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/line immunoassays euroimmun antibody/product/EUROIMMUN
    Average 90 stars, based on 1 article reviews
    line immunoassays euroimmun antibody - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    ana line immunoassays imtec-ana-lia-maxx  (HUMAN Gesellschaft)
    90
    HUMAN Gesellschaft ana line immunoassays imtec-ana-lia-maxx
    Cross-sectional analysis of sputum cytology in the four clusters identified by the St George's Respiratory Questionnaire (SGRQ) at visit 1. SGRQ clusters are characterised based on a) sputum cell differential count, b) inflammatory markers and c) antinuclear <t>antibodies</t> <t>(ANAs).</t> Significance of difference (p<0.05) between clusters was determined using multiple analysis of covariance (MANCOVA) and between individual clusters and no post-acute coronavirus disease 2019 sequalae (NoPACS) using a Mann–Whitney U-test, without covariate adjustment. Dotted lines indicate cut-off >9.7 million cells·g −1 of sputum for indication of ongoing infection. ▴ (in aqua): Participant with pulmonary fibrosis. <t>ANA</t> comparison was based on continuous mean quantitative values. PACS: post-acute COVID-19 sequalae; IL: interleukin; TNF: tumour necrosis factor; eos: eosinophils; MQV: mean quantitative value.
    Ana Line Immunoassays Imtec Ana Lia Maxx, supplied by HUMAN Gesellschaft, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ana line immunoassays imtec-ana-lia-maxx/product/HUMAN Gesellschaft
    Average 90 stars, based on 1 article reviews
    ana line immunoassays imtec-ana-lia-maxx - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    euroline autoimmune inflammatory myopathies 16 ag line immunoassay  (EUROIMMUN)
    90
    EUROIMMUN euroline autoimmune inflammatory myopathies 16 ag line immunoassay
    Cross-sectional analysis of sputum cytology in the four clusters identified by the St George's Respiratory Questionnaire (SGRQ) at visit 1. SGRQ clusters are characterised based on a) sputum cell differential count, b) inflammatory markers and c) antinuclear <t>antibodies</t> <t>(ANAs).</t> Significance of difference (p<0.05) between clusters was determined using multiple analysis of covariance (MANCOVA) and between individual clusters and no post-acute coronavirus disease 2019 sequalae (NoPACS) using a Mann–Whitney U-test, without covariate adjustment. Dotted lines indicate cut-off >9.7 million cells·g −1 of sputum for indication of ongoing infection. ▴ (in aqua): Participant with pulmonary fibrosis. <t>ANA</t> comparison was based on continuous mean quantitative values. PACS: post-acute COVID-19 sequalae; IL: interleukin; TNF: tumour necrosis factor; eos: eosinophils; MQV: mean quantitative value.
    Euroline Autoimmune Inflammatory Myopathies 16 Ag Line Immunoassay, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/euroline autoimmune inflammatory myopathies 16 ag line immunoassay/product/EUROIMMUN
    Average 90 stars, based on 1 article reviews
    euroline autoimmune inflammatory myopathies 16 ag line immunoassay - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Cross-sectional analysis of sputum cytology in the four clusters identified by the St George's Respiratory Questionnaire (SGRQ) at visit 1. SGRQ clusters are characterised based on a) sputum cell differential count, b) inflammatory markers and c) antinuclear antibodies (ANAs). Significance of difference (p<0.05) between clusters was determined using multiple analysis of covariance (MANCOVA) and between individual clusters and no post-acute coronavirus disease 2019 sequalae (NoPACS) using a Mann–Whitney U-test, without covariate adjustment. Dotted lines indicate cut-off >9.7 million cells·g −1 of sputum for indication of ongoing infection. ▴ (in aqua): Participant with pulmonary fibrosis. ANA comparison was based on continuous mean quantitative values. PACS: post-acute COVID-19 sequalae; IL: interleukin; TNF: tumour necrosis factor; eos: eosinophils; MQV: mean quantitative value.

    Journal: ERJ Open Research

    Article Title: Respiratory burden in post-acute COVID-19 sequelae: a longitudinal study of airway and systemic inflammation and clinical outcomes

    doi: 10.1183/23120541.01331-2024

    Figure Lengend Snippet: Cross-sectional analysis of sputum cytology in the four clusters identified by the St George's Respiratory Questionnaire (SGRQ) at visit 1. SGRQ clusters are characterised based on a) sputum cell differential count, b) inflammatory markers and c) antinuclear antibodies (ANAs). Significance of difference (p<0.05) between clusters was determined using multiple analysis of covariance (MANCOVA) and between individual clusters and no post-acute coronavirus disease 2019 sequalae (NoPACS) using a Mann–Whitney U-test, without covariate adjustment. Dotted lines indicate cut-off >9.7 million cells·g −1 of sputum for indication of ongoing infection. ▴ (in aqua): Participant with pulmonary fibrosis. ANA comparison was based on continuous mean quantitative values. PACS: post-acute COVID-19 sequalae; IL: interleukin; TNF: tumour necrosis factor; eos: eosinophils; MQV: mean quantitative value.

    Article Snippet: ANAs were assessed utilising ANA line immunoassays (IMTEC-ANA-LIA-MAXX, Human Diagnostics, Germany) as previously described in serum [ ] and sputa [ ].

    Techniques: MANN-WHITNEY, Infection, Comparison

    Cross-sectional analysis of systemic inflammation in the four clusters identified by the St George's Respiratory Questionnaire (SGRQ) at visit 1. SGRQ clusters are characterised based on a) white cell counts and their subtypes, b) inflammatory markers, and c) antinuclear antibodies (ANAs) in serum. Significant difference (p<0.05) between clusters was determined using a multiple analysis of covariance (MANCOVA) and between individual clusters and no post-acute coronavirus disease 2019 sequalae (NoPACS) using a Mann–Whitney U-test, without covariate adjustment. # : indicates significant difference (p<0.05) with NoPACS. ▴ (in aqua): Participant with pulmonary fibrosis. ▪ (in magenta): Participant with bronchiectasis. ANA comparison based on continuous mean quantitative values. PACS: post-acute COVID-19 sequalae; NLR: neutrophil to lymphocyte ratio; CRP: C-reactive protein; IL: interleukin; TNF: tumour necrosis factor; MQV: mean quantitative value.

    Journal: ERJ Open Research

    Article Title: Respiratory burden in post-acute COVID-19 sequelae: a longitudinal study of airway and systemic inflammation and clinical outcomes

    doi: 10.1183/23120541.01331-2024

    Figure Lengend Snippet: Cross-sectional analysis of systemic inflammation in the four clusters identified by the St George's Respiratory Questionnaire (SGRQ) at visit 1. SGRQ clusters are characterised based on a) white cell counts and their subtypes, b) inflammatory markers, and c) antinuclear antibodies (ANAs) in serum. Significant difference (p<0.05) between clusters was determined using a multiple analysis of covariance (MANCOVA) and between individual clusters and no post-acute coronavirus disease 2019 sequalae (NoPACS) using a Mann–Whitney U-test, without covariate adjustment. # : indicates significant difference (p<0.05) with NoPACS. ▴ (in aqua): Participant with pulmonary fibrosis. ▪ (in magenta): Participant with bronchiectasis. ANA comparison based on continuous mean quantitative values. PACS: post-acute COVID-19 sequalae; NLR: neutrophil to lymphocyte ratio; CRP: C-reactive protein; IL: interleukin; TNF: tumour necrosis factor; MQV: mean quantitative value.

    Article Snippet: ANAs were assessed utilising ANA line immunoassays (IMTEC-ANA-LIA-MAXX, Human Diagnostics, Germany) as previously described in serum [ ] and sputa [ ].

    Techniques: MANN-WHITNEY, Comparison